What Physidia does

Physidia S.A.S. is a privately held French medical device company headquartered in Saint-Barthélemy-d'Anjou, France, founded in 2010. The company designs, manufactures, and distributes the S³ Monitor, a compact hemodialysis machine purpose-built for frequent home hemodialysis (FHDD), along with the proprietary SeCoHD® Push-Pull method for enhanced middle molecule toxin removal. Its product ecosystem includes the S³ Monitor, the PhysiNums® remote monitoring service, a full range of consumables (dialysate cassettes, blood lines, lactate and bicarbonate dialysate bags), accessories (racks, patient card and programmer system, transport case), and accompanying training and technical support services. All products are CE marked under EU MDR 2017/745 and are manufactured centrally in France.

Physidia serves three primary stakeholder groups: end-stage renal disease patients performing frequent home hemodialysis (typically 4-6 sessions per week, 2-3 hours each), prescribing nephrologists and dialysis center staff, and a network of specialized dealers/distributors across more than 30 countries. The business model combines upfront hardware sales of the S³ Monitor with a recurring consumables stream tied to each treatment session, supplemented by training programs, technical support, and remote monitoring services. Sales occur through both direct relationships with healthcare facilities and channel partners, with localized websites and support infrastructure for France, Germany, Spain, and other markets. Clinical credibility is anchored by the RECAP (10 centers, 92 patients, 2-year follow-up) and RETRO (13 centers, 80 patients, 249 treatments) French multicenter studies demonstrating efficacy, hemodynamic stability, and quality-of-life outcomes including a 25% return-to-employment rate among studied patients.

The company operates as an independent S.A.S. with €20,154,490 in share capital, 51-100 employees, and no disclosed parent company or institutional investor ownership. Leadership includes CEO Didier Candelot and founder Michel Houdou. Physidia has no mobile applications, no public API, and no disclosed AI/ML capabilities; competitive differentiation rests on regulatory compliance, proprietary dialysis method, clinical evidence, and a hard-to-replicate international dealer network with embedded training and support.

Name

Physidia

Legal name

Physidia S.A.S.

Website

https://physidia.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Physidia S.A.S. is a French medical device company that designs, manufactures, and distributes the S³ Monitor and consumables for frequent home hemodialysis across 30+ countries via dealers and direct healthcare facility sales.

Ownership category

akta.pro rank

Product category

Home Hemodialysis Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Hemodialysis Machines & Systems (HLAHAKAA)

akta.pro secondary industries

Home Dialysis Equipment & Remote Monitoring (HLAHAKAG), Renal Replacement Therapy Consumables (Bloodlines, Filters, Cartridges) (HLAHAKAH), Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC)

Keywords

• Home hemodialysis
• Medical devices
• Nephrology equipment
• Dialysis consumables
• Remote patient monitoring

Headquarters

HQ city

Saint-barthelemy-d'anjou

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales (Hardware): Physidia generates revenue through the sale of medical devices including the S³ Monitor and associated equipment such as dialysis cassettes, blood line systems, dialysate bags, and patient card programmers. These are regulated medical products sold to healthcare facilities and patients.
2. Consumables and Supplies: Ongoing revenue from consumables required for home dialysis including dialysate (lactate and bicarbonate based), blood lines, and other disposable materials used during each treatment session.
3. Technical Support and Services: Technical support services including phone assistance (Monday-Friday 8am-8pm, Saturday 8am-2pm), equipment maintenance, exchange programs for malfunctioning devices, and loaner monitor provision.
4. Training and Education Services: Training programs for healthcare professionals on S³ Monitor operation and patient therapy training, delivered in partnership with local distribution partners.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Physidia designs, manufactures, and distributes the S³ Monitor, a compact hemodialysis machine purpose-built for frequent home hemodialysis (FHDD), along with proprietary SeCoHD® (Push-Pull) treatment technology, a full line of consumables (dialysate cassettes, blood lines, lactate and bicarbonate dialysate bags), accessories, and complementary services including PhysiNums® remote monitoring, technical support, and clinical training programs for healthcare professionals and patients.

Product overview

Physidia offers a comprehensive home hemodialysis solution centered around the S³ Monitor, a compact dialysis machine designed for frequent home hemodialysis (FHDD). The product portfolio includes the proprietary SeCoHD® (Push-Pull) method for enhanced middle molecule clearance, a complete range of consumables (dialysate cassettes, blood lines, lactate and bicarbonate dialysate bags), accessories (racks, holders, patient card system, transport case), and services (PhysiNums® remote monitoring, technical support, and training programs). The ecosystem is designed to enable patients to perform short, frequent dialysis sessions at home with healthcare professional oversight.

Differentiator

Problem solved

Functional benefit

Brands

• S³ Monitor: A compact home hemodialysis monitor designed for frequent home hemodialysis (HDDQ/FHHD), featuring intuitive interface, real-time monitoring, and safety alarms.
• SeCoHD
• PhysiNums

Products and services

• S³ Monitor A compact hemodialysis monitor specifically designed for frequent home hemodialysis (FHDD), featuring an intuitive user interface for patient self-management, real-time monitoring with safety alarms, optimized blood purification, and flexibility in hemodialyzer selection. Sold to healthcare facilities, dialysis centers, and through distribution partners for use by chronic kidney disease patients at home.
• PhysiNums® Remote Monitoring Service A remote data monitoring service that enables healthcare professionals to access and review dialysis session data from patients performing home hemodialysis with the S³ Monitor, supporting optimized clinical follow-up of remote patients.
• Dialysis Consumables (Cassettes, Blood Lines, Dialysate Bags) Recurring-use disposable supplies required for each S³ Monitor treatment session, including dialysate cassettes, blood line systems, and pre-filled lactate-based and bicarbonate-based dialysate bags. Sold on an ongoing basis to patients and healthcare providers using the S³ system.
• Patient Card Programmer and Patient Cards A programmer device and patient-specific cards that store individualized treatment parameters for the S³ Monitor, allowing prescribers to configure per-patient therapy settings that are then read by the monitor at home.
• Technical Support and Maintenance Service Standardized exchange and maintenance program for S³ Monitors, with phone support available Monday–Friday 8am–8pm and Saturday 8am–2pm, centralized manufacturing of certified spare parts at Saint-Barthélemy-d'Anjou, and provision of loaner monitors during device servicing.
• Training Programs Comprehensive training offering including initial training, refresher courses, expert training, and specialist courses delivered through learning videos, practical guides, an e-learning platform, and webinars, targeted at healthcare professionals, distribution partners, and patients learning to operate the S³ Monitor at home.

Quantifiable outcome

• 25% of patients returned to employment during RECAP study 2-year follow-up period
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Healthcare Facilities and NephrologistscoreStrategic or Co-development PartnerClose collaboration with hospitals, clinics, and nephrologists ensures integration of home dialysis into care pathways and provides safe and effective patient management. These partnerships ensure proper patient selection, training, and ongoing clinical monitoring.
• Specialized Dealers and DistributorscoreChannel Partner/ Reseller/ DistributorNetwork of specialized dealers operating in over 30 countries, providing local market access with first-class support and technical assistance. Partners receive comprehensive training programs to master Physidia technologies and effectively support medical professionals in implementing devices.
• Patient AssociationsminorStrategic or Co-development PartnerSupport for patient associations and collaboration with health organizations contributes to awareness building and promotes the global development of home dialysis. Associations provide patient support and education resources.

Scale indicators5 records

Recent moves1 record

Expansion highlights5 records

Broad incumbents

• Fresenius Medical Care: The world's largest dialysis services and products company, operating in-center clinics globally and selling home hemodialysis systems (including the legacy NxStage portfolio acquired in 2017). Directly comparable as a home dialysis hardware and consumables provider with much broader scale and vertical integration into clinic operations.
• Baxter International: Sells home peritoneal and hemodialysis systems (HomeChoice, Amia, Sharesource remote monitoring platform) and competes head-to-head with Physidia in European home dialysis accounts. Comparable as a regulated home dialysis device + consumables + connected health player with substantially greater scale.
• B. Braun Avitum: Dialysis division of B. Braun, offering hemodialysis machines, consumables, and services across Europe. Comparable as a competing manufacturer of regulated hemodialysis equipment and consumables serving European clinics and home programs.
• DaVita: Largest U.S. dialysis services provider with growing home hemodialysis programs and partner relationships with device manufacturers. Comparable as the demand-side buyer of home hemodialysis technology and an indirect peer via its role shaping home dialysis adoption and reimbursement.

Direct peers

• Outset Medical: U.S.-based developer of the Tablo Hemodialysis System, designed for use across inpatient, outpatient, and home settings with integrated water purification and a connected data platform. Highly comparable as a compact, easy-to-use hemodialysis system purpose-built for home use with a recurring consumables model.
• Quanta Dialysis Technologies: UK-based company commercializing the SC+ portable hemodialysis system for home and clinic use. Directly comparable as a compact, intuitive home hemodialysis device with regulatory clearances in Europe and the U.S. and a similar razor/blade consumables model.
• NxStage Medical (Fresenius Medical Care): Pioneer of the System One home hemodialysis machine, now owned by Fresenius. Closely comparable as a frequent home hemodialysis platform with patient-friendly design; Physidia's S³ Monitor is positioned as a next-generation alternative to the legacy NxStage system.

Regional players

• Asahi Kasei Medical: Japanese manufacturer of dialysis membranes, dialyzers, and related renal care products with a strong Asia-Pacific footprint. Comparable as a renal/dialysis consumables and equipment manufacturer serving similar clinical use cases in a different primary geography.
• JMS Co., Ltd. Japanese medical device manufacturer with a dialysis product portfolio including hemodialysis machines and blood lines. Comparable as a renal therapy equipment and consumables supplier operating primarily in Asia rather than Europe.

Others

• Medtronic: While diversified across many therapy areas, Medtronic participates in adjacent renal care categories and represents the type of large strategic that could partner with or acquire a focused home dialysis asset like Physidia to enter the category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCqoIcQ4K94VaCiaTsoxkPBw
• Facebookfacebook.com/Physidia
• LinkedInlinkedin.com/company/physidia
• Xx.com/physidia

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Physidia